214 related articles for article (PubMed ID: 25267063)
21. Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
Beloueche-Babari M; Arunan V; Troy H; te Poele RH; te Fong AC; Jackson LE; Payne GS; Griffiths JR; Judson IR; Workman P; Leach MO; Chung YL
Cancer Res; 2012 Feb; 72(4):990-1000. PubMed ID: 22194463
[TBL] [Abstract][Full Text] [Related]
22. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies.
Eliyahu G; Kreizman T; Degani H
Int J Cancer; 2007 Apr; 120(8):1721-30. PubMed ID: 17236204
[TBL] [Abstract][Full Text] [Related]
23. Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
Granata A; Nicoletti R; Perego P; Iorio E; Krishnamachary B; Benigni F; Ricci A; Podo F; Bhujwalla ZM; Canevari S; Bagnoli M; Mezzanzanica D
Oncotarget; 2015 May; 6(13):11216-30. PubMed ID: 25796169
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
25. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
[TBL] [Abstract][Full Text] [Related]
26. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
[TBL] [Abstract][Full Text] [Related]
27. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.
Shah T; Wildes F; Penet MF; Winnard PT; Glunde K; Artemov D; Ackerstaff E; Gimi B; Kakkad S; Raman V; Bhujwalla ZM
NMR Biomed; 2010 Jul; 23(6):633-42. PubMed ID: 20623626
[TBL] [Abstract][Full Text] [Related]
28. Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.
Gokhale S; Lu W; Zhu S; Liu Y; Hart RP; Rabinowitz JD; Xie P
J Immunol; 2020 Jan; 204(2):459-471. PubMed ID: 31826940
[TBL] [Abstract][Full Text] [Related]
29. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.
Miyake T; Parsons SJ
Oncogene; 2012 Mar; 31(11):1431-41. PubMed ID: 21822308
[TBL] [Abstract][Full Text] [Related]
30. Choline phospholipid metabolism: a target in cancer cells?
Ackerstaff E; Glunde K; Bhujwalla ZM
J Cell Biochem; 2003 Oct; 90(3):525-33. PubMed ID: 14523987
[TBL] [Abstract][Full Text] [Related]
31. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
Glunde K; Jie C; Bhujwalla ZM
Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.
Nimmagadda S; Glunde K; Pomper MG; Bhujwalla ZM
Neoplasia; 2009 May; 11(5):477-84. PubMed ID: 19412432
[TBL] [Abstract][Full Text] [Related]
34. A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling.
Clem BF; Clem AL; Yalcin A; Goswami U; Arumugam S; Telang S; Trent JO; Chesney J
Oncogene; 2011 Jul; 30(30):3370-80. PubMed ID: 21423211
[TBL] [Abstract][Full Text] [Related]
35. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype.
Vesuna F; Penet MF; Mori N; Bhujwalla ZM; Raman V
Mol Cell Biochem; 2023 Apr; 478(4):939-948. PubMed ID: 36136285
[TBL] [Abstract][Full Text] [Related]
36. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.
Romanska HM; Tiziani S; Howe RC; Günther UL; Gulzar Z; Lalani el-N
Neoplasia; 2009 Dec; 11(12):1301-8. PubMed ID: 20019838
[TBL] [Abstract][Full Text] [Related]
37. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
[TBL] [Abstract][Full Text] [Related]
38. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
39. Choline kinase alpha expression during RA-induced neuronal differentiation: role of C/EBPβ.
Domizi P; Aoyama C; Banchio C
Biochim Biophys Acta; 2014 Apr; 1841(4):544-51. PubMed ID: 24440820
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
Glunde K; Serkova NJ
Pharmacogenomics; 2006 Oct; 7(7):1109-23. PubMed ID: 17054420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
